Accustem Sciences Inc. (ACUT)

AI-Powered SEC Filing Analysis

Annual Report Filed: 2026-04-14

Key Insights

  • Accustem Sciences Inc. (ACUT) reported financial results for the fiscal year 2025, with increases in common stock, additional paid-in capital, and related party subscription receivables compared to the prior year.
  • The company renewed its directors and officers liability insurance agreement in 2025 and 2024, indicating management's focus on risk mitigation and corporate governance.
  • ACUT has granted employee stock options and warrants during the reported periods, which could dilute existing shareholders if exercised.
Filing tone (AI): Neutral
View Original Filing →

Filings on this page are at least 90 days old. In the app, any new Accustem Sciences Inc. filing is analysed the moment you open it.

Download on theApp Store Get it onGoogle Play

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.